Clinical assessment of patients with severe coronary artery disease treated with Yiqi Tongluo

J Biol Regul Homeost Agents. 2019 Sep-Oct;33(5):1515-1520. doi: 10.23812/19-12-L.

Authors

X Q Yang^#¹, C L Du^#², W Wang¹, Z Liu¹, Y R Dong¹, Q M Feng¹, L P Yao^#³

Affiliations

¹ Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
² Zhenxin Community Health Service Center, Jiading, Shanghai, China.
³ Department of Cardiothoracic Surgery, Xinhua hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

^# Contributed equally.

PMID: 31650821
DOI: 10.23812/19-12-L

No abstract available

Keywords: Qi-deficiency and blood-stasis syndrome; Yiqi Tongluo formulation; severe coronary artery disease.

Copyright 2019 Biolife Sas. www.biolifesas.org.

Publication types

Letter

MeSH terms

Coronary Artery Disease / drug therapy*
Drugs, Chinese Herbal / therapeutic use*
Humans
Medicine, Chinese Traditional

Substances

Drugs, Chinese Herbal
tongluo